XyloCor is a startup based in the United States, 2 tracked investors.
Based in the United States, XyloCor is a startup founded in 2018. Brouky records 2 investors associated with the company.
XyloCor Therapeutics develops proprietary gene therapies to treat advanced coronary artery disease and other cardiovascular conditions.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.